Get the Stockscreener App
18.27
4.76%
0.83
After Hours:
18.34
0.07
+0.38%
Quidelortho Corp stock is traded at $18.27, with a volume of 1.28M.
It is up +4.76% in the last 24 hours and up +35.33% over the past month.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
See More
Previous Close:
$17.44
Open:
$17.5
24h Volume:
1.28M
Relative Volume:
0.57
Market Cap:
$1.25B
Revenue:
$2.66B
Net Income/Loss:
$-1.21B
P/E Ratio:
-1.0253
EPS:
-17.82
Net Cash Flow:
$-159.40M
1W Performance:
+0.11%
1M Performance:
+35.33%
6M Performance:
-45.70%
1Y Performance:
-42.09%
1-Day Range:
$17.17
$18.57
1-Week Range:
$15.49
$18.77
52-Week Range:
$9.92
$35.58
Quidelortho Corp Stock (QDEL) Company Profile
Name
Quidelortho Corp
Sector
Industry
Phone
(858) 552-1100
Address
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corp
|
18.27 | 1.25B | 2.66B | -1.21B | -159.40M | -17.82 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quidelortho Corp Stock (QDEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-25 | Downgrade | Citigroup | Buy → Neutral |
| May-08-25 | Upgrade | Jefferies | Hold → Buy |
| Dec-11-24 | Upgrade | Citigroup | Neutral → Buy |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Sep-19-24 | Resumed | UBS | Neutral |
| Sep-05-24 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-04-24 | Downgrade | UBS | Neutral → Sell |
| Feb-14-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-14-22 | Upgrade | UBS | Sell → Neutral |
| Sep-19-22 | Initiated | Citigroup | Neutral |
| Jul-20-22 | Initiated | UBS | Sell |
| Jun-17-22 | Resumed | JP Morgan | Neutral |
| Feb-22-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-12-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-26-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Mar-08-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-18 | Reiterated | Barclays | Overweight |
| Jan-04-18 | Upgrade | CL King | Neutral → Buy |
| Sep-19-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jul-18-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jul-18-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Apr-25-17 | Reiterated | Canaccord Genuity | Hold |
| Feb-17-17 | Initiated | CL King | Neutral |
| Dec-16-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jun-13-16 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Feb-18-16 | Reiterated | Barclays | Overweight |
| Feb-09-16 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
| Dec-14-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-02-15 | Initiated | Barclays | Overweight |
| Jul-31-13 | Reiterated | Canaccord Genuity | Buy |
| Mar-03-11 | Downgrade | Wedbush | Outperform → Neutral |
View All
Quidelortho Corp Stock (QDEL) Latest News
QuidelOrtho (QDEL) Jefferies Global Healthcare Conference 2026 Summary - Quartr
QuidelOrtho Corp (QDEL) Shares Surge 4.8% -- What GF Score of 43 Tells Investors - GuruFocus
QuidelOrtho taps former Masimo executive Micah Young as CFO - MSN
QuidelOrtho (QDEL) Is Down 5.1% After Broad Russell Growth Index RemovalWhat's Changed - simplywall.st
Spotting Winners: QuidelOrtho (NASDAQ:QDEL) And Healthcare Equipment and Supplies Stocks In Q1 - Yahoo Finance
Neuberger Berman holds 3.53M shares of QuidelOrtho (QDEL) - Stock Titan
QuidelOrtho: Too Much Uncertainty Around Earnings Keeping Short-Interest Elevated (QDEL) - Seeking Alpha
Citi Maintains QuidelOrtho(QDEL.US) With Hold Rating, Raises Target Price to $18 - Moomoo
QuidelOrtho Corp highlights diagnostics portfolio as investors track Nasdaq listing - ad-hoc-news.de
QDEL stock eyes best day in over a year — point-of-care sale talks ignite rally - MSN
QuidelOrtho (QDEL) moves 32.2% higher: Will this strength last? - MSN
QuidelOrtho | 4: Statement of changes in beneficial ownership of securities-Officer Hanson Bryan Michael - Moomoo
QDELQuidelOrtho Corp Earnings - Finviz
QDEL Maintained by JP Morgan -- Price Target Raised to $12.00 - GuruFocus
J.P. Morgan Maintains QuidelOrtho(QDEL.US) With Sell Rating, Cuts Target Price to $12 - Moomoo
Is QuidelOrtho Corp (QDEL) a Bargain After 3.9% Drop? GF Value S - GuruFocus
Stocks making big moves yesterday: AppLovin, QuidelOrtho, Rocket Lab, Pinterest, and Zscaler - Barchart.com
QuidelOrtho (QDEL) Moves 32.2% Higher: Will This Strength Last? - Yahoo Finance
Does QuidelOrtho's (QDEL) Index Exit and New CFO Hint at a Shift in Growth Identity? - Yahoo Finance
QuidelOrtho (QDEL) stock trades up, here is why - MSN
Form 4 Quidel Corporation For: 29 June By Investing.com - Investing.com Canada
QuidelOrtho | 4: Statement of changes in beneficial ownership of securities-Director WIDDER KENNETH J - Moomoo
QuidelOrtho (QDEL) director receives 15,532 restricted stock units as equity award - Stock Titan
QuidelOrtho (QDEL) Stock Trades Up, Here Is Why - StockStory
Market Chatter: QuidelOrtho Weighs Sale of Point-of-Care Testing Business - Moomoo
Why is Quidel stock surging today? By Investing.com - Investing.com India
QDEL Stock Eyes Best Day In Over A Year — Point-Of-Care Sale Talks Ignite Rally - Stocktwits
QuidelOrtho (QDEL) Soars 33% Amid Sale Speculation - GuruFocus
QuidelOrtho (QDEL) to Sell Point-of-Care Testing Unit, Targeting $1.5 Billion Valuation - GuruFocus
Jefferies reiterates Quidel stock Hold rating on PoC business sale - Investing.com UK
Jefferies on QuidelOrtho (QDEL): 'we view a potential sale as a net positive' - StreetInsider
QuidelOrtho Corporation(NasdaqGS:QDEL) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
QuidelOrtho Corporation(NasdaqGS: QDEL) dropped from Russell 3000 Growth Benchmark - marketscreener.com
QuidelOrtho Corporation(NasdaqGS:QDEL) dropped from Russell 3000E Growth Benchmark - marketscreener.com
QuidelOrtho plans to sell testing unit for $1.5B: FT - MSN
QuidelOrtho (QDEL) Pursues $1.5B Sale of Testing Unit Amid Debt Reduction Efforts - GuruFocus
Diagnostics Firm QuidelOrtho Looks at Testing Unit Sale, Says FT - Bloomberg.com
QuidelOrtho looks to sell testing unit as PE circles healthcare companiesFT - TradingView
QuidelOrtho Corporation Actuals & Estimates (NASDAQ:QDEL) - TradingView
QuidelOrtho Corp (QDEL) Valuation: PE, PB & Fair Value Analysis - TradingKey
QuidelOrtho Appoints Micah Young as Chief Financial Officer - Sahm
QuidelOrtho names Micah Young as chief financial officer - Investing.com UK
QuidelOrtho names Micah Young as chief financial officer By Investing.com - Investing.com South Africa
QuidelOrtho Names Micah Young Chief Financial Officer - citybiz
QuidelOrtho Appoints Micah Young Chief Financial Officer - marketscreener.com
Press Release: QuidelOrtho Appoints Micah Young as Chief Financial Officer - Moomoo
QDEL Technical Analysis & Stock Price Forecast - Intellectia AI
Quidelortho Corp Stock (QDEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Quidelortho Corp Stock (QDEL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Strobeck Matthew | Director |
Feb 13 '26 |
Buy |
23.96 |
10,000 |
239,586 |
27,775 |
| Busky Joseph M. | Chief Financial Officer |
Feb 13 '26 |
Buy |
23.66 |
3,370 |
79,742 |
10,290 |
| Blaser Brian J. | President and CEO |
Feb 13 '26 |
Buy |
23.59 |
10,540 |
248,661 |
40,073 |
| RHOADS ANN D | Director |
Dec 10 '25 |
Buy |
28.27 |
750 |
21,206 |
15,021 |
| Wilkins Joseph D Jr. | Director |
Nov 26 '25 |
Buy |
27.95 |
370 |
10,343 |
11,876 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Option Exercise |
15.74 |
7,021 |
110,511 |
41,087 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Sale |
27.81 |
4,026 |
111,965 |
37,061 |
2.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):